Other

Deferred Tax Assets, Net

Merck & Co. Deferred Tax Assets, Net decreased by 47.3% to $1.17B in Q4 2025 compared to the prior quarter. Over 2 years (FY 2023 to FY 2025), Deferred Tax Assets, Net shows relatively stable performance with a 3.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryEfficiency
SignalHigher is better
VolatilityModerate
First reportedQ4 2023
Last reportedQ4 2025Feb 24, 2026

How to read this metric

A positive net asset indicates a future tax benefit, while a negative net balance indicates a future tax liability.

Detailed definition

This represents the net balance of deferred tax assets after accounting for valuation allowances and offsetting deferred...

Peer comparison

Standard financial reporting metric for tax positions across all industries.

Metric ID: other_deferred_tax_assets_liabilities_net

Historical Data

3 periods
 Q4 '23Q4 '24Q4 '25
Value$1.10B$2.21B$1.17B
QoQ Change+101.8%-47.3%
YoY Change+101.8%-47.3%
Range$1.10B$2.21B
Avg YoY Growth+27.2%
Median YoY Growth+27.2%

Deferred Tax Assets, Net at Other Companies

Frequently Asked Questions

What is Merck & Co.'s deferred tax assets, net?
Merck & Co. (MRK) reported deferred tax assets, net of $1.17B in Q4 2025.
What is the long-term trend for Merck & Co.'s deferred tax assets, net?
Over 2 years (2023 to 2025), Merck & Co.'s deferred tax assets, net has grown at a 3.1% compound annual growth rate (CAGR), from $1.10B to $1.17B.
What does deferred tax assets, net mean?
The net value of all deferred tax assets after subtracting valuation allowances and deferred tax liabilities.